The neurological presentation of ceruloplasmin gene mutations

Alisdair McNeill1, Massimo Pandolfo, Jens Kuhn

  • 1Department of Clinical Genetics, NIHR, Birmingham Women's Hospital, Birmingham, UK. Amcneill@doctors.org.uk

European Neurology
|August 1, 2008
PubMed

Insights

Aceruloplasminemia, a rare iron metabolism disorder, primarily affects the brain and eyes. This review highlights cognitive impairment, ataxia, and retinal degeneration as key neurological symptoms in affected individuals.

Area of Science:

  • Neurology
  • Genetics
  • Metabolic Disorders

Background:

  • Aceruloplasminemia is an autosomal recessive disorder caused by ceruloplasmin gene mutations.
  • It involves abnormal iron metabolism with potential neurological and systemic consequences.

Purpose of the Study:

  • To delineate the neurological phenotype of aceruloplasminemia.
  • To analyze clinical presentations across different genotypes and disease severities.

Main Methods:

  • Systematic review of published case reports.
  • Inclusion of an unpublished case for comprehensive analysis.
  • Analysis of patient demographics, clinical signs, and diagnosis age.

Main Results:

  • Thirty-three cases (32 published, 1 unpublished) were analyzed.
  • Homozygous patients frequently exhibited cognitive impairment (42%), cerebellar ataxia (46%), and retinal degeneration (75%).
  • Heterozygotes showed milder neurological signs, and no genotype-phenotype correlation was found, though homozygotes had more severe disease.

Conclusions:

  • Aceruloplasminemia presents with a distinct neurological phenotype, primarily affecting cognition, motor control, and vision.
  • Early diagnosis and understanding the spectrum of symptoms are crucial for managing this rare iron metabolism disorder.

Related Concept Videos

Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...